ViroPharma, Inc. (NASDAQ:VPHM)

CAPS Rating: 4 out of 5

A biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings.

Recs

0
Player Avatar Reddragyn (68.13) Submitted: 1/25/2012 11:36:10 AM : Outperform Start Price: $23.50 VPHM Score: -30.49

MF

Featured Broker Partners


Advertisement